GDC-0077 Uses, Dosage, Side Effects and more
GDC-0077 is under investigation in clinical trial NCT03006172 (To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer).
| Trade Name | GDC-0077 |
| Generic | GDC-0077 |
| Type | |
| Formula | C18H19F2N5O4 |
| Weight | Average: 407.378 Monoisotopic: 407.140510438 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
